Consistent regenerative therapeutics

Rhynexa is a founder-led biotech company developing consistent and scalable regenerative off-the-shelf products.

Why we matter:

Many biological therapies show promise, but variability and difficult standardization remain major barriers to broader use.

Rhynexa is building more defined regenerative products designed for greater consistency and scalability.

Consistency

More defined starting material may reduce variability between batches.

Scalability

Standardized product approaches can support more reliable manufacturing.

Product clarity

Better-defined products may support clearer quality control and product development.

Our current focus

Rhynexa’s current focus is building off-the-shelf cell based therapies rendering them widely accessible for patients.

Let's connect

We welcome conversations with collaborators, scientific partners, and stakeholders interested in regenerative medicine and scalable biological product development.

Rhynexa GmbH
Elisabethenanlage 25
4051 Basel
Switzerland